SEP 13, 2017 5:51 AM PDT

FDA Allows Peanut Allergy Prevention Claim on Baby Foods

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

For the first time, the US Food and Drug Administration is changing its label recommendation based on a qualified health claim to prevent food allergy. Indeed, peanut-containing foods suitable for infants may now disclose the potential for reducing the risk of a peanut allergy.

Peanut allergy is one of the most common food allergies. In some people, the reaction can be so severe that it triggers anaphylaxis resulting in death. Stories such as these have made parents and doctors especially cautious over the years, and rightfully so. Concerned parents didn’t introduce peanut foods until their child was well into toddlerhood.

But we may have swung a little too far. Within the last two decades, peanut allergies in the US have tripled in number. What gives? Researchers think that in an effort to prevent peanut allergy, people are inadvertently creating immune systems that are even more sensitive to the proteins in peanuts. Paradoxically, the conventional wisdom that prevents giving peanut product to babies may actually be behind the increased risk for peanut allergy.

According to a recent landmark trial, researchers found that peanut exposure at a young age, as early as four months, had positive effects on the immune system. Instead of inducing allergies, as doctors previously predicted, the exposure decreased the risk of a peanut allergy in later adulthood by as much as 80 percent. This is true even for children who had a high risk of developing a peanut allergy, perhaps due to having severe eczema or an egg allergy.

In light of the recent findings, the National Institute of Health issued new guidelines that, for the first time, encouraged parents to ease off on the peanut brakes. With the supervision of pediatricians, parents were encouraged to introduce peanut-containing foods to infants as early as four to six months old.

Now, the FDA is expanding on this recommendation and making labels on peanut-containing foods more clear. They are specifically responding to the health claim that states “for most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age.”

Per the FDA, the goal is “to make sure parents are abreast of the latest science and can make informed decisions about how they choose to approach these challenging issues.” The label, however, will still advise parents to consult with their child’s physicians before making dietary changes.

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 07, 2019
Genetics & Genomics
OCT 07, 2019
Risk Factors for Gout Revealed by Genome-Wide Association Study
Gout is a common type of arthritis, and causes severe and sudden pain, redness and swelling in the joints....
OCT 16, 2019
Genetics & Genomics
OCT 16, 2019
A 'Molecular Clock' for Determining a Child's Age
This tool can aid in the diagnosis of developmental disorders, including autism spectrum disorder....
NOV 06, 2019
Clinical & Molecular DX
NOV 06, 2019
Opioid Addiction Can be Controlled Using an In-Brain Chip Technology: First U.S. Clinical Trial
Opioid addiction is a long-lasting (chronic) disease that can cause major health, social, and economic problems. Opioids are a class of drugs that act...
NOV 26, 2019
Clinical & Molecular DX
NOV 26, 2019
Looking into the eyes of MS patients for personalized therapies
Blurred or double vision, and in extreme cases, complete vision loss are amongst the earliest symptoms of multiple sclerosis (MS). In this devastating dise...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
FEB 11, 2020
Clinical & Molecular DX
FEB 11, 2020
Portable device turns smartphones into diagnostic labs
Your smartphone lets you connect with friends, stores your memories, sends work emails and pays for your groceries. Soon, it could even help diagnose if yo...
Loading Comments...